Guest guest Posted January 28, 2011 Report Share Posted January 28, 2011 Thanks Amruta for your single handed discussion. Well done. Sorry, even I did not chip in, as was busy with the rituals associated with death of my father. Welcome again as moderator for NetRUM. NetRUM is now open for free posts. Tip: It is good time to buy big companies, Group A, stocks in Indian market. Amongst those, hunt for those which are available at 52 week low prices and also have lower PE ratio. Vijay Groupie > > Respected members, > I hope this e-discussion was helpful in understanding pharmacogenomics.I am thankful to Dr. Thawani sir for giving me the opportunity to conduct this discussion. Thank you sir. > I conclude this topic as pharmacogenomics pretends fascinating implications for medical & pharma sector.reaping the dividends of this field requires a clear focus on technologies & a synchronized multidisciplinary effort.Also there is need of formulating regulatory policies, considering the vast domain of the field. There is need of combined efforts by government, regulatory authority & research teams to ensure high efficacy,minimum toxicity drug to the common man at a feasible low cost. > > > Regards, > Dr. Amruta Dawari > JR 1, Dept of pharmacology, > GMCH, Nagpur. > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.